Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89801-89850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05238519
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
PHASE3Recruiting
300 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors2 locations
NCT05138133
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
PHASE3Recruiting
360 participants
Started: Feb 15, 2022 · Completed: Jul 7, 2028
1 condition1 sponsor233 locations
NCT05197738
Research Framework Exploring Sleep Health
N/ARecruiting
100,000 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2041
4 conditions1 sponsor1 location
NCT05328960
The Pandemic's Effect on Diagnosis and Treatment of Rectal Cancer
N/ARecruiting
8,000 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07205003
Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders
N/ARecruiting
140 participants
Started: Feb 15, 2022 · Completed: Sep 18, 2026
2 conditions1 sponsor1 location
NCT05408507
Care Planning Framework in Advanced Cancer (ABC123)
NARecruiting
70 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05300685
Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty
PHASE3Recruiting
60 participants
Started: Feb 15, 2022 · Completed: Mar 1, 2026
1 condition2 sponsors2 locations
NCT06870123
Randomized MINIMA Stem with DELTA TT or DELTA ST-C
NAActive, not recruiting
120 participants
Started: Feb 15, 2022 · Completed: Feb 15, 2029
1 condition1 sponsor1 location
NCT06115122
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
N/ARecruiting
3,000 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2041
7 conditions7 sponsors1 location
NCT04307992
AneuFix - Prophylactic Sac Filling
NARecruiting
5 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05214391
A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
PHASE2Recruiting
30 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04740580
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
EARLY_PHASE1Recruiting
52 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05121376
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema
PHASE1/PHASE2Active, not recruiting
44 participants
Started: Feb 15, 2022 · Completed: Nov 30, 2028
2 conditions1 sponsor16 locations
NCT03435939
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
EARLY_PHASE1Active, not recruiting
16 participants
Started: Feb 15, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05568043
The Reducing REVISITS Study: A Cluster RCT
NARecruiting
24 participants
Started: Feb 15, 2022 · Completed: Mar 31, 2026
2 conditions6 sponsors1 location
NCT05377853
Advanced Spatiomotor Rehabilitation for Navigation in Blindness & Visual Impairment
NARecruiting
75 participants
Started: Feb 15, 2022 · Completed: Feb 29, 2024
4 conditions1 sponsor1 location
NCT05603546
A Prospective, Multicenter, Observational Study on the Treatment of Chronic Common Femoral Artery Bifurcation Occlusion
N/ARecruiting
300 participants
Started: Feb 15, 2022 · Completed: Feb 14, 2026
1 condition1 sponsor1 location
NCT05280340
Anakinra for Preterm Infants Pilot
PHASE1/PHASE2Active, not recruiting
25 participants
Started: Feb 15, 2022 · Completed: Mar 31, 2025
2 conditions5 sponsors2 locations
NCT05217849
Multi-domain Online Therapeutic Investigation Of Neurocognition (MOTION)
NAActive, not recruiting
80 participants
Started: Feb 15, 2022 · Completed: Jun 30, 2026
2 conditions4 sponsors1 location
NCT05587270
CLIMB: Climbers' Longitudinal Attitudes to Injuries, Mental Health and Body Image
N/ARecruiting
366 participants
Started: Feb 15, 2022 · Completed: Dec 1, 2025
4 conditions2 sponsors1 location
NCT05401292
Skin Preparation for Elective Foot and Ankle Surgery
PHASE4Recruiting
100 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05246267
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
N/ARecruiting
60 participants
Started: Feb 15, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05293899
The Pathogenesis of Depression - Possible Autoimmune Mechanisms
N/ARecruiting
200 participants
Started: Feb 15, 2022 · Completed: Apr 15, 2026
2 conditions1 sponsor1 location
NCT05465564
My Hearing Experience - a Study About the Effect of Personality and Lifestyle on Everyday Hearing
N/AActive, not recruiting
40 participants
Started: Feb 15, 2022 · Completed: Dec 30, 2023
2 conditions1 sponsor1 location
NCT05393427
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors
PHASE1Active, not recruiting
4 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors4 locations
NCT02379377
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
PHASE1Recruiting
110 participants
Started: Feb 15, 2022 · Completed: May 31, 2027
5 conditions2 sponsors1 location
NCT05244642
A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma
PHASE3Recruiting
60 participants
Started: Feb 15, 2022 · Completed: Mar 30, 2026
1 condition2 sponsors6 locations
NCT05091268
Effect of Physical Activity and Pain Education on Endometriosis-associated Pain
NAActive, not recruiting
83 participants
Started: Feb 15, 2022 · Completed: Mar 1, 2026
1 condition4 sponsors1 location
NCT06537986
A Neuro-cognitive and Psychosocial Intervention Module in People With Epilepsy
NARecruiting
60 participants
Started: Feb 15, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05775679
Test-Retest Reliability, Responsiveness and Interpretability of CLEFT-Q
N/ARecruiting
260 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2028
1 condition5 sponsors1 location
NCT04428164
Enhancing Patient Experience of Pain and Sleep Through Non-Pharmacological Strategies
N/AEnrolling by invitation
320 participants
Started: Feb 15, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
PHASE2Active, not recruiting
120 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
21 conditions1 sponsor166 locations
NCT05137743
Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness
NAActive, not recruiting
80 participants
Started: Feb 15, 2022 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT05218824
Collection of Head Images During Radiotherapy
N/AActive, not recruiting
32 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05248620
Prophylactic Antibiotic Treatment in Hemodialysis
NARecruiting
800 participants
Started: Feb 14, 2022 · Completed: May 31, 2029
1 condition1 sponsor7 locations
NCT05143021
Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme
N/AActive, not recruiting
500 participants
Started: Feb 14, 2022 · Completed: Jan 1, 2026
2 conditions1 sponsor3 locations
NCT05200351
Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design
NARecruiting
35 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors3 locations
NCT05272618
Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries
N/ARecruiting
150 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2028
3 conditions3 sponsors1 location
NCT05257213
Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
NARecruiting
100 participants
Started: Feb 14, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT05503134
Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
PHASE1/PHASE2Recruiting
20 participants
Started: Feb 14, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05183204
Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
PHASE2Recruiting
33 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05317429
Glycaemic Responses to Carbohydrate-rich Meals (GlyCarb)
NAEnrolling by invitation
25 participants
Started: Feb 14, 2022 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT05204927
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
PHASE3Active, not recruiting
439 participants
Started: Feb 14, 2022 · Completed: Feb 28, 2029
1 condition1 sponsor52 locations
NCT06546267
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
N/ARecruiting
2,500 participants
Started: Feb 14, 2022 · Completed: Dec 14, 2027
1 condition1 sponsor1 location
NCT05074680
COVID-19 Antibody Responses In Cystic Fibrosis
N/AActive, not recruiting
5 participants
Started: Feb 14, 2022 · Completed: Jul 31, 2025
1 condition3 sponsors2 locations
NCT05041153
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
EARLY_PHASE1Recruiting
15 participants
Started: Feb 14, 2022 · Completed: Dec 30, 2025
33 conditions1 sponsor1 location
NCT05801380
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
N/ARecruiting
60 participants
Started: Feb 14, 2022 · Completed: Feb 14, 2026
1 condition1 sponsor1 location
NCT05254574
Sustained Acoustic Medicine for Osteoarthritis Pain
PHASE1Recruiting
200 participants
Started: Feb 14, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05210361
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers
N/AActive, not recruiting
192 participants
Started: Feb 14, 2022 · Completed: Jul 31, 2027
2 conditions2 sponsors1 location
NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
PHASE1Recruiting
77 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2026
4 conditions2 sponsors1 location